Curt Hartman | executive |
Todd Garner | executive |
Vikramjeet Chopra | analyst |
Robert Marcus | analyst |
Frederick Wise | analyst |
Matthew O'Brien | analyst |
Michael Matson | analyst |
Kristen Stewart | analyst |
Carolyn Huszagh | analyst |
Thank you for standing by, and welcome to CONMED's Q3 Fiscal Year 2023 Earnings Call. [Operator Instructions]Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties as those terms are defined under the Federal Securities laws. Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results.The company's actual results may differ materially from its current expectations. Please refer to the risks and other uncertainties disclosed under the forward-looking information in today's press release as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual results to differ materially.